GR1010905B - Δισκιο που περιεχει τορασεμιδη - Google Patents

Δισκιο που περιεχει τορασεμιδη Download PDF

Info

Publication number
GR1010905B
GR1010905B GR20240100275A GR20240100275A GR1010905B GR 1010905 B GR1010905 B GR 1010905B GR 20240100275 A GR20240100275 A GR 20240100275A GR 20240100275 A GR20240100275 A GR 20240100275A GR 1010905 B GR1010905 B GR 1010905B
Authority
GR
Greece
Prior art keywords
torasemide
containing tablet
tablet
sugar
disintegrant
Prior art date
Application number
GR20240100275A
Other languages
English (en)
Inventor
Χρηστος Σωτηριου
Παναγιωτα Κουρκουλιωτη
Original Assignee
Win Medica Φαρμακευτικη Ανωνυμη Εταιρεια,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Win Medica Φαρμακευτικη Ανωνυμη Εταιρεια, filed Critical Win Medica Φαρμακευτικη Ανωνυμη Εταιρεια,
Priority to GR20240100275A priority Critical patent/GR1010905B/el
Publication of GR1010905B publication Critical patent/GR1010905B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)

Abstract

Δισκίο που περιέχει τορασεμίδη, ή φαρμακευτικά αποδεκτό άλας της, και τουλάχιστον 35% κατά βάρος σάκχαρο, ή αλκοόλη σακχάρου. Το δισκίο μπορεί να περιέχει προαιρετικά επιπλέον έκδοχα, όπως επιπλέον αραιωτικό, συνδετικό, αποσαθρωτικό, λιπαντικό και βελτιωτή ροής.
GR20240100275A 2024-04-15 2024-04-15 Δισκιο που περιεχει τορασεμιδη GR1010905B (el)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GR20240100275A GR1010905B (el) 2024-04-15 2024-04-15 Δισκιο που περιεχει τορασεμιδη

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20240100275A GR1010905B (el) 2024-04-15 2024-04-15 Δισκιο που περιεχει τορασεμιδη

Publications (1)

Publication Number Publication Date
GR1010905B true GR1010905B (el) 2025-03-10

Family

ID=95559131

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20240100275A GR1010905B (el) 2024-04-15 2024-04-15 Δισκιο που περιεχει τορασεμιδη

Country Status (1)

Country Link
GR (1) GR1010905B (el)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035135A1 (en) * 2000-02-17 2002-03-21 Minutza Leibovici Stable pharmaceutical formulation comprising torsemide modification II
US20030119882A1 (en) * 2001-10-22 2003-06-26 Markus Maegerlein Solid pharmaceutical composition containing torasemide
CN113750068A (zh) * 2021-10-28 2021-12-07 江苏睿实生物科技有限公司 一种托拉塞米片及其制备方法
WO2022180531A1 (en) * 2021-02-23 2022-09-01 Teva Pharmaceutical Industries Ltd Fixed-dose pharmaceutical compositions
CN115778912A (zh) * 2021-09-09 2023-03-14 苏中药业集团股份有限公司 一种含有托拉塞米的片剂及其制备方法

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035135A1 (en) * 2000-02-17 2002-03-21 Minutza Leibovici Stable pharmaceutical formulation comprising torsemide modification II
US20030119882A1 (en) * 2001-10-22 2003-06-26 Markus Maegerlein Solid pharmaceutical composition containing torasemide
WO2022180531A1 (en) * 2021-02-23 2022-09-01 Teva Pharmaceutical Industries Ltd Fixed-dose pharmaceutical compositions
CN115778912A (zh) * 2021-09-09 2023-03-14 苏中药业集团股份有限公司 一种含有托拉塞米的片剂及其制备方法
CN113750068A (zh) * 2021-10-28 2021-12-07 江苏睿实生物科技有限公司 一种托拉塞米片及其制备方法

Similar Documents

Publication Publication Date Title
MX2021003739A (es) Derivados de quinolino-pirrolidin-2-ona como inhibidores del gen mutado de ataxia telangiectasia (atm) y el uso de los mismos en el tratamiento de tumores sólidos.
TNSN04213A1 (en) High drug load tablet
ID26236A (id) Turunan benzamida untuk pengobatan penyakit yang diperantarai oleh sitokina
EA200700566A1 (ru) Фармацевтические композиции, включающие леветирацетам, и способы их получения
TNSN08173A1 (en) Dispersible tablets comprising deferasirox
MX2024014628A (es) Compuesto para inhibir o degradar bcl6 y uso de este en farmacia
SA516371218B1 (ar) صيغة توليفة صيدلانية تشتمل على الأميلوديبين واللوسارتان والرسيوفاستاتين
PH12014500937A1 (en) 5-ht 1a receptor substype agonist
MX2021004474A (es) Compuestos que contienen deuterio.
EP4647068A3 (en) Formulations of ag10
TN2022000092A1 (en) Oral complement factor d inhibitors
MX2022012056A (es) Pirrolopirimidinaminas como inhibidores del sistema del complemento.
MX2023014547A (es) Proceso para la preparacion de inhibidores de familia de receptores tipo nod con dominio pirina 3 (nlrp3).
MX2025005223A (es) Agonistas del estimulador de genes de interferon (sting)
MX2023009954A (es) Compuestos de aminopirimidina y métodos de uso de estos.
NO20072445L (no) Krystallinske former av 3-[5-klor-4-[(2,4-difluorbenzyl)oksy]-6-oksypyrimidin-1 (6H)-yl]-N-(2-hydroksyetyl)-4-metylbenzamid
GR1010905B (el) Δισκιο που περιεχει τορασεμιδη
PH12022553516A1 (en) Novel pyrazole derivatives
MX2020013729A (es) Compuestos de cianotriazol y usos de los mismos.
MX2022006104A (es) Composicion farmaceutica oral que comprende compuesto de carbamato y metodo de preparacion para la misma.
MX2024007395A (es) Tetrahidropiridazinas, composiciones que las comprenden y usos de estas.
MX2023015377A (es) Sal de potasio cristalina de 1-etil-n-((1,2,3,5,6,7-hexahidro-s-in dacen-4-il)carbamoil)piperidin-4-sulfonamida.
TW200730176A (en) Formulations of quinolinones
AU2021326530A8 (en) Dosage form compositions comprising an inhibitor of btk and mutants thereof
MX2022004213A (es) Derivados de 2-azaspiro[3.4]octano como agonistas de m4.

Legal Events

Date Code Title Description
PG Patent granted

Effective date: 20250409